Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer

SL Coleridge, A Bryant, S Kehoe… - Cochrane Database of …, 2021 - cochranelibrary.com
Background Epithelial ovarian cancer presents at an advanced stage in the majority of
women. These women require surgery and chemotherapy for optimal treatment …

Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer

J Morrison, K Haldar, S Kehoe… - Cochrane Database of …, 2012 - cochranelibrary.com
Background Epithelial ovarian cancer presents at an advanced stage in the majority of
women. These women require surgery and chemotherapy for optimal treatment …

Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis

RE Bristow, DS Chi - Gynecologic oncology, 2006 - Elsevier
OBJECTIVE: To determine the overall survival and relative effect of multiple prognostic
variables in cohorts of patients with advanced-stage ovarian cancer treated with platinum …

Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer

AE Axtell, MH Lee, RE Bristow, SC Dowdy… - Journal of clinical …, 2007 - ascopubs.org
Purpose Identify features on preoperative computed tomography (CT) scans to predict
suboptimal primary cytoreduction in patients treated for advanced ovarian cancer in …

Does neoadjuvant chemotherapy increase optimal cytoreduction rate in advanced ovarian cancer? Meta-analysis of 21 studies

S Kang, BH Nam - Annals of surgical oncology, 2009 - Springer
Background The purpose of the current study is to analyze the existing data regarding
neoadjuvant chemotherapy (NAC) in advanced epithelial ovarian cancer (EOC) using a …

Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease

JY Hou, MG Kelly, H Yu, JN McAlpine, M Azodi… - Gynecologic …, 2007 - Elsevier
OBJECTIVES.: To compare the survival and peri-operative morbidities of patients with
advanced epithelial ovarian cancer (EOC, stage IIIC and IV) who were treated with primary …

Delaying the primary surgical effort for advanced ovarian cancer: a systematic review of neoadjuvant chemotherapy and interval cytoreduction

RE Bristow, EL Eisenhauer, A Santillan, DS Chi - Gynecologic oncology, 2007 - Elsevier
OBJECTIVE.: To summarize the existing data on interval cytoreductive surgery and
neoadjuvant chemotherapy as alternative treatment strategies for patients with advanced …

Interval debulking surgery for advanced epithelial ovarian cancer

S Tangjitgamol, S Manusirivithaya… - Cochrane Database …, 2013 - cochranelibrary.com
Background Interval debulking surgery (IDS), following induction or neoadjuvant
chemotherapy, may have a role in treating advanced epithelial ovarian cancer (stage III to …

Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced ovarian epithelial cancer

SL Coleridge, A Bryant, S Kehoe… - Cochrane Database of …, 2021 - cochranelibrary.com
Background Epithelial ovarian cancer presents at an advanced stage in the majority of
women. These women require a combination of surgery and chemotherapy for optimal …

Epithelial ovarian, fallopian tube, and peritoneal cancer

JS Berek, ML Friedlander… - Holland‐Frei Cancer …, 2016 - Wiley Online Library
Overview Ovarian cancer is one of the most treatable solid tumors, as the majority will
respond temporarily to surgery and cytotoxic agents. The disease, however, frequently …